Upper extremity outcome measures for collagen VI-related myopathy and LAMA2-related muscular dystrophy
- PMID: 28087121
- PMCID: PMC5318262
- DOI: 10.1016/j.nmd.2016.11.017
Upper extremity outcome measures for collagen VI-related myopathy and LAMA2-related muscular dystrophy
Abstract
Congenital muscular dystrophy (CMD) comprises a rare group of genetic muscle diseases that present at birth or early during infancy. Two common subtypes of CMD are collagen VI-related muscular dystrophy (COL6-RD) and laminin alpha 2-related dystrophy (LAMA2-RD). Traditional outcome measures in CMD include gross motor and mobility assessments, yet significant motor declines underscore the need for valid upper extremity motor assessments as a clinical endpoint. This study validated a battery of upper extremity measures in these two CMD subtypes for future clinical trials. For this cross-sectional study, 42 participants were assessed over the same 2-5 day period at the National Institutes of Health Clinical Center. All upper extremity measures were correlated with the Motor Function Measure 32 (MFM32). The battery of upper extremity assessments included the Jebsen Taylor Hand Function Test, Quality of Upper Extremity Skills Test (QUEST), hand held dynamometry, goniometry, and MyoSet Tools. Spearman Rho was used for correlations to the MFM32. Pearson was performed to correlate the Jebsen, QUEST, hand-held dynamometry, goniometry and the MyoSet Tools. Correlations were considered significant at the 0.01 level (2-tailed). Significant correlations were found between both the MFM32 and MFM Dimension 3 only (Distal Motor function) and the Jebsen, QUEST, MyoGrip and MyoPinch, elbow flexion/extension ROM and myometry. Additional correlations between the assessments are reported. The Jebsen, the Grasp and Dissociated Movements domains of the QUEST, the MyoGrip and the MyoPinch tools, as well as elbow ROM and myometry were determined to be valid and feasible in this population, provided variation in test items, and assessed a range of difficulty in CMD. To move forward, it will be of utmost importance to determine whether these upper extremity measures are reproducible and sensitive to change over time.
Keywords: Collagen VI-related muscular dystrophy; Congenital muscular dystrophy; Laminin alpha 2-related dystrophy; QUEST, Jebsen, Motor Function Measure; Upper extremity measures.
Copyright © 2016 Elsevier B.V. All rights reserved.
Figures
Similar articles
-
Responsiveness and Minimal Clinically Important Difference of the Motor Function Measure in Collagen VI-Related Dystrophies and Laminin Alpha2-Related Muscular Dystrophy.Arch Phys Med Rehabil. 2021 Apr;102(4):604-610. doi: 10.1016/j.apmr.2020.10.116. Epub 2020 Nov 6. Arch Phys Med Rehabil. 2021. PMID: 33166523 Free PMC article.
-
Improving Reproducibility of Phenotypic Assessments in the DyW Mouse Model of Laminin-α2 Related Congenital Muscular Dystrophy.J Neuromuscul Dis. 2017;4(2):115-126. doi: 10.3233/JND-170217. J Neuromuscul Dis. 2017. PMID: 28550268 Free PMC article. Review.
-
Electrical impedance myography in individuals with collagen 6 and laminin α-2 congenital muscular dystrophy: a cross-sectional and 2-year analysis.Muscle Nerve. 2018 Jan;57(1):54-60. doi: 10.1002/mus.25629. Epub 2017 Apr 25. Muscle Nerve. 2018. PMID: 28224647 Free PMC article.
-
Results of a two-year pilot study of clinical outcome measures in collagen VI- and laminin alpha2-related congenital muscular dystrophies.Neuromuscul Disord. 2015 Jan;25(1):43-54. doi: 10.1016/j.nmd.2014.09.010. Epub 2014 Sep 28. Neuromuscul Disord. 2015. PMID: 25307854 Free PMC article.
-
[Muscular dystrophies due to alterations at extracellular space level: congenital muscular dystrophy caused by merosin deficiency].Rev Neurol. 1999 Jan 16-31;28(2):141-9. Rev Neurol. 1999. PMID: 10101782 Review. Spanish.
Cited by
-
Patient-Reported Outcome Measures in Neuromuscular Diseases: A Scoping Review.J Neuromuscul Dis. 2024;11(3):567-577. doi: 10.3233/JND-240003. J Neuromuscul Dis. 2024. PMID: 38517800 Free PMC article. Review.
-
Management of motor rehabilitation in individuals with muscular dystrophies. 1st Consensus Conference report from UILDM - Italian Muscular Dystrophy Association (Rome, January 25-26, 2019).Acta Myol. 2021 Jun 30;40(2):72-87. doi: 10.36185/2532-1900-046. eCollection 2021 Jun. Acta Myol. 2021. PMID: 34355124 Free PMC article.
-
LAMA2-related muscular dystrophy: Natural history of a large pediatric cohort.Ann Clin Transl Neurol. 2020 Oct;7(10):1870-1882. doi: 10.1002/acn3.51172. Epub 2020 Sep 10. Ann Clin Transl Neurol. 2020. PMID: 32910545 Free PMC article.
-
Rare variant in LAMA2 gene causing congenital muscular dystrophy in a Sudanese family. A case report.Acta Myol. 2019 Mar 1;38(1):21-24. eCollection 2019 Mar. Acta Myol. 2019. PMID: 31309178 Free PMC article.
-
Motor function performance in individuals with RYR1-related myopathies.Muscle Nerve. 2019 Jul;60(1):80-87. doi: 10.1002/mus.26491. Muscle Nerve. 2019. PMID: 31004442 Free PMC article.
References
-
- Zupan A. Assessment of the functional abilities of the upper limbs in patients with neuromuscular diseases. Disabil Rehabil. 1996;18:69–75. - PubMed
-
- Mercuri E, Sewry C, Brown SC, Muntoni F. Congenital muscular dystrophies. Semin Pediatr Neurol. 2002;9(2):120–31. - PubMed
-
- Mazzone ES, Vasco G, Palermo C, et al. A critical review of functional assessment tools for upper limbs in Duchenne muscular dystrophy. Dev Med Child Neurol. 2012;54:879–85. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous